Spemann® (Speman®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbsppills
Composition:

Each tablet contains:

Active components:

Powders:

Orchis of male tubers

Orchis mascula L.

65,0 mg

Asternant of long-leaved seed

Astercantha longifolia (L.) Nees

32,0 mg

Compass Seed Lettuce

Lactuca scariola L.

16,0 mg

Velvet beans of itchy seeds

Mucuna pruriens (L.) DC.

16 ,0 mg

Tin disulphide (gold

mosaic)

16,0 mg

Dry extracts:

Arguies of beautiful roots

Argyreia speciosa Sweet

32,0 mg

Yakortsev creeping fruit

Tribulus terrestris L.

32,0 mg

Mesh stamping

Leptadenia reticulate W.Et A.

32,0 mg

Parmelia pearl thallus

Parmelia perlata (Huds.) Ach.

16,0 mg

Excipients:

Microcrystalline cellulose 32.4 mg; carmellose sodium 9.6 mg; magnesium stearate 2.0 mg; crospovidone 7.0 mg; silicon dioxide colloid 2.0 mg.

Description:

Round, biconvex tablets from light brown to dark brown with interspersed.

Pharmacotherapeutic group:treatment of prostatic adenoma of plant origin
ATX: & nbsp
  • Other drugs for the treatment of urological diseases
    • Pharmacodynamics:

    The complex of biologically active substances of the preparation Spemant® tablets has a prostanoactive antidisuric, anti-edematous, anti-inflammatory, improving microcirculation in the tissues of the prostate gland.

    The active substances of plants that make up Spemann®, stimulate spermatogenesis, increase the activity of spermatozoa,reduce stagnant phenomena in the prostate gland with chronic prostatitis, reduce the severity of dysuric disorders in benign prostatic hyperplasia (difficulty, frequent urination, nocturia, etc.).

    Pharmacokinetics:

    Data on pharmacokinetics a multicomponent herbal preparation Speman® in the dosage form of the tablet is absent. The activity of the drug is due to the mutually reinforcing combined effect of its components, which is typical for herbal medicines. Since the activity of the drug can not be fully attributed to any single compound, pharmacokinetic studies of multicomponent plant preparations, including Spemann® tablets, are not feasible.

    Indications:

    Benign hyperplasia stage 1-2, chronic prostatitis (I know symptomatic therapy).

    Contraindications:

    Hypersensitivity to individual components of the drug.

    Children under 18 years.

    Pregnancy and lactation:

    Application in women, including during pregnancy and during breastfeeding is not provided.

    Dosing and Administration:

    Inside. After meal.

    Benign hyperplasia prostate, chronic prostatitis: initially 2 tablets 2-3 times a day, followed by a lowering of the maintenance dose.

    The course of treatment is not less than 3 months.

    After 2-3 months, the course of treatment can be repeated.

    Side effects:

    Allergic reactions are possible.

    If any of the side effects indicated in the manual are aggravated, or if you notice any other side effects not listed in the instructions, inform the doctor about it.

    Overdose:

    To date, there is no information about an overdose. To avoid overdose, follow the instructions for use.

    Treatment in case of accidental overdose of Speman®: symptomatic.

    Interaction:

    It is recommended to use in the course of complex therapy together with other drugs used in benign prostatic hyperplasia.

    Special instructions:

    As the therapeutic effect of Spemann® develops gradually, systematic medical monitoring of the condition of the prostate gland is necessary. In the case of acute urinary retention, it is urgent to see a doctor.

    The drug is not an alternative to surgical treatment if it is necessary, but it can be used to prepare patients for surgical intervention on the prostate gland.

    The drug does not reduce the potency and libido.

    When discontinuation of the Spemann® drug, the pill on the occurrence of the "withdrawal" syndrome was not reported.

    Special measures when skipping one or more doses of the drug is not required. If a patient once or several times misses a drug, you should continue taking the drug at the recommended scheme in the instructions, not doubling the dose.

    Special precautions are not required when destroying an unused medicinal product.

    Effect on the ability to drive transp. cf. and fur:

    The drug does not affect the performance of potentially hazardous activities, requiring special attention and quick reactions (driving and other vehicles, working with moving mechanisms, dispatcher / operator work, etc.).

    Form release / dosage:

    Pills.

    Packaging:

    For 100 tablets in a plastic bottle of high density polyethylene with a screw cap.The neck of the bottle is additionally tightened with aluminum foil with the company logo.

    Each vial with instructions for use is placed in a cardboard box.

    Storage conditions:

    Store in a dry place, at a temperature of 10 to 30 ° C.

    Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:ПN011523 / 02
    Date of registration:01.03.2011
    The owner of the registration certificate:Himalaya Drag CoHimalaya Drag Co India
    Manufacturer: & nbsp
    Representation: & nbspTRANSATLANTIC INTERNATIONAL CJSC TRANSATLANTIC INTERNATIONAL CJSC Russia
    Information update date: & nbsp19.03.2016
    Illustrated instructions
      Instructions
      Up